Cargando…
PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in vivo
mRNA-based vaccines and candidate therapeutics have great potential in various medical fields. For the delivery of mRNA into target cells and tissues, lipid formulations are often employed. However, this approach could cause the activation of immune responses, making it unsuitable for the treatment...
Autores principales: | Periyasamy, Kapilraj, Maloverjan, Maria, Biswas, Abhijit, Remm, Anu, Pook, Martin, Rebane, Ana, Pooga, Margus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374019/ https://www.ncbi.nlm.nih.gov/pubmed/37521463 http://dx.doi.org/10.3389/fphar.2023.1219761 |
Ejemplares similares
-
Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14
por: Ervin, Egle-Helene, et al.
Publicado: (2019) -
Effect of small molecule signaling in PepFect14 transfection
por: Gestin, Maxime, et al.
Publicado: (2020) -
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation
por: Ezzat, Kariem, et al.
Publicado: (2011) -
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo
por: EL Andaloussi, Samir, et al.
Publicado: (2011) -
Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6
por: Dash-Wagh, Suvarna, et al.
Publicado: (2012)